KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference12 articles.
1. Multiple myeloma;Kumar;Nat Rev Dis Primer,2017
2. Promising therapies in multiple myeloma;Bianchi;Blood.,2015
3. Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation;Lionetti;Oncotarget.,2015
4. Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy;Mulligan;Blood,2014
5. Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy;Liu;Acta Pharm Sin B.,2018
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. DNA Sequencing of CD138 Cell Population Reveals TP53 and RAS-MAPK Mutations in Multiple Myeloma at Diagnosis;Cancers;2024-01-14
2. A Comprehensive Targeted Panel of 282 Genes: Unveiling Key Biomarkers in Multiple Myeloma;2023-11-01
3. Chemotherapy-induced toxic epidermal necrolysis in a patient with multiple myeloma, a case report and literature review;Frontiers in Oncology;2023-08-02
4. A challenging diagnosis of rare co-existent multiple myeloma and prostate adenocarcinoma: a systematic review of case reports;Journal of the Pakistan Medical Association;2023-07-15
5. Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study;Cancers;2023-02-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3